Needham analyst Mayank Tandon lowered the firm’s price target on Genpact (G) to $50 from $55 and keeps a Buy rating on the shares. The company posted solid Q1 results, beating top and bottom line estimates, and added 80 new logos, but the positive print was clouded by a weak Q2 guide and lower FY25 outlook, primarily due to heightened macro uncertainty causing large deal signings to be pushed out post “Liberation Day”, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G:
- Genpact price target lowered to $50 from $56 at Baird
- Genpact’s Resilience and Growth Potential Amid Economic Uncertainties: A Buy Recommendation
- Genpact’s Strategic Growth and Technological Advancements Drive Buy Rating Despite Lowered Guidance
- Genpact Sees Strong Q1 Growth in 2025
- Genpact’s Strategic Positioning Amid Timing Challenges: A Buy Opportunity